Typhoid: Background
Typhoid: Background
Typhoid: Background
Background
Typhoid fever, also known as enteric fever, is a potentially fatal multisystemic illness caused
primarily by Salmonella enterica, subspecies enterica serovar typhi and, to a lesser extent,
related serovars paratyphi A, B, and C.
The protean manifestations of typhoid fever make this disease a true diagnostic challenge. The
classic presentation includes fever, malaise, diffuse abdominal pain, and constipation. Untreated,
typhoid fever is a grueling illness that may progress to delirium, obtundation, intestinal
hemorrhage, bowel perforation, and death within 1 month of onset. Survivors may be left with
long-term or permanent neuropsychiatric complications.
S typhi has been a major human pathogen for thousands of years, thriving in conditions of poor
sanitation, crowding, and social chaos. It may have responsible for the Great Plague of Athens at
the end of the Pelopennesian War. The name S typhi is derived from the ancient Greek typhos, an
ethereal smoke or cloud that was believed to cause disease and madness. In the advanced stages
of typhoid fever, the patient's level of consciousness is truly clouded. Although antibiotics have
markedly reduced the frequency of typhoid fever in the developed world, it remains endemic in
developing countries.
S paratyphi causes the same syndrome but appears to be a relative newcomer. It may be taking
over the typhi niche, in part, because of immunological naivete among the population and
incomplete coverage by vaccines that target typhi.
Note that some writers refer to the typhoid and paratyphoid fever as distinct syndromes caused
by the typhi versus paratyphi serovars, while others use the term typhoid fever for a disease
caused by either one. We use the latter terminology. We refer to these serovars collectively as
typhoidal salmonella.
recently have traveled to endemic areas. This is in comparison to the 1920s, when over 35,000
cases were reported in the U.S. This improvement is the result of improved environmental
sanitation. Mexico and South America are the most common areas for U.S. citizens to contract
typhoid fever. India, Pakistan, and Egypt are also known high-risk areas for developing this
disease. Worldwide, typhoid fever affects more than 21 million people annually, with over
200,000 patients dying of the disease.
If traveling to endemic areas, you should consult with your health-care professional and discuss
if you should receive vaccination for typhoid fever.
poor appetite;
abdominal pain;
headaches;
generalized aches and pains;
People with typhoid fever usually have a sustained fever as high as 103 F-104 F (39 C-40 C).
Chest congestion develops in many patients, and abdominal pain and discomfort are common.
The fever becomes constant. Improvement occurs in the third and fourth week in those without
complications. About 10% of patients have recurrent symptoms (relapse) after feeling better for
one to two weeks. Relapses are actually more common in individuals treated with antibiotics.
What is the treatment for typhoid fever, and what is the prognosis?
Typhoid fever is treated with antibiotics that kill the Salmonella bacteria. Prior to the use of
antibiotics, the fatality rate was 20%. Death occurred from overwhelming infection, pneumonia,
intestinal bleeding, or intestinal perforation. With antibiotics and supportive care, mortality has
been reduced to 1%-2%. With appropriate antibiotic therapy, there is usually improvement within
one to two days and recovery within seven to 10 days.
Several antibiotics are effective for the treatment of typhoid fever. Chloramphenicol was the
original drug of choice for many years. Because of rare serious side effects, chloramphenicol has
been replaced by other effective antibiotics. The choice of antibiotics needs to be guided by
identifying the geographic region where the organism was acquired and the results of cultures
once available. (Certain strains from South America show a significant resistance to some
antibiotics.) Ciprofloxacin (Cipro) is the most frequently used drug in the U.S. for non-pregnant
patients. Ceftriaxone (Rocephin), an intramuscular injection medication, is an alternative for
pregnant patients. Ampicillin (Omnipen, Polycillin, Principen) and trimethoprimsulfamethoxazole (Bactrim, Septra) are frequently prescribed antibiotics although resistance has
been reported in recent years. If relapses occur, patients are retreated with antibiotics.
The carrier state, which occurs in 3%-5% of those infected, can be treated with prolonged
antibiotics. Often, removal of the gallbladder, the site of chronic infection, will cure the carrier
state.
REFERENCE:
United States. Centers for Disease Control and Prevention. "Typhoid Fever."
<http://www.cdc.gov/ncidod/dbmd/diseaseinfo/TyphoidFever_g.htm>.
8. Chiou CS, Wei HL, Mu JJ, Liao YS, Liang SY, Liao CH, et al. Salmonella enterica
serovar Typhi variants in long-term carriers. J Clin Microbiol. 2013 Feb. 51(2):669-72.